ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for the ...

ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in metabolic dysfunction-associated steatotic liver disease (MASLD). The ...

Please provide your email address to receive an email when new articles are posted on . Treatment responders demonstrated significant reductions in iron corrected T1 and liver fat content. Optimal ...

New findings from the DIRECT PLUS, 18-month-long lifestyle intervention trial underscores the potential to observe and signify alterations of MRI-assessed liver fat with proteomics according to new ...

Liver disease is a major global health concern, accounting for approximately 2 million deaths per year worldwide 1. The most common causes include alcohol misuse, obesity or viral hepatitis and in the ...

Ultrasound is currently the standard imaging tool for HCC surveillance. However, prior evidence has suggested that contrast-enhanced MRI—particularly with gadoxetate disodium—may detect tumors more ...

GE HealthCare has launched its next-generation of LOGIQ ultrasound systems, designed to enhance clinical imaging and expedite ...

Colorectal liver metastases (CRLM), cancer that has spread from the colon or rectum to the liver, have a deadly reputation. Due to its pervasive spread, typical cancer treatments like chemotherapy and ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...